Marc A Emerson1, Yvonne M Golightly1, Xianming Tan2,3, Allison E Aiello1, Katherine E Reeder-Hayes2, Andrew F Olshan1,2, H Shelton Earp2, Melissa A Troester4. 1. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 2. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 3. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 4. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. troester@email.unc.edu.
Abstract
PURPOSE: Understanding breast cancer mortality disparities by race and age is complex due to disease heterogeneity, comorbid disease, and the range of factors influencing access to care. It is important to understand how these factors group together within patients. METHODS: We compared socioeconomic status (SES) and comorbidity factors in the Carolina Breast Cancer Study Phase 3 (CBCS3, 2008-2013) to those for North Carolina using the 2010 Behavioral Risk Factor Surveillance Study. In addition, we used latent class analysis of CBCS3 data to identify covariate patterns by SES/comorbidities, barriers to care, and tumor characteristics and examined their associations with race and age using multinomial logistic regression. RESULTS: Major SES and comorbidity patterns in CBCS3 participants were generally similar to patterns in the state. Latent classes were identified for SES/comorbidities, barriers to care, and tumor characteristics that varied by race and age. Compared to white women, black women had lower SES (odds ratio (OR) 6.3, 95% confidence interval (CI) 5.2, 7.8), more barriers to care (OR 5.6, 95% CI 3.9, 8.1) and several aggregated tumor aggressiveness features. Compared to older women, younger women had higher SES (OR 0.5, 95% CI 0.4, 0.6), more barriers to care (OR 2.1, 95% CI 1.6, 2.9) and aggregated tumor aggressiveness features. CONCLUSIONS: CBCS3 is representative of North Carolina on comparable factors. Patterns of access to care and tumor characteristics are intertwined with race and age, suggesting that interventions to address disparities will need to target both access and biology.
PURPOSE: Understanding breast cancer mortality disparities by race and age is complex due to disease heterogeneity, comorbid disease, and the range of factors influencing access to care. It is important to understand how these factors group together within patients. METHODS: We compared socioeconomic status (SES) and comorbidity factors in the Carolina Breast Cancer Study Phase 3 (CBCS3, 2008-2013) to those for North Carolina using the 2010 Behavioral Risk Factor Surveillance Study. In addition, we used latent class analysis of CBCS3 data to identify covariate patterns by SES/comorbidities, barriers to care, and tumor characteristics and examined their associations with race and age using multinomial logistic regression. RESULTS: Major SES and comorbidity patterns in CBCS3 participants were generally similar to patterns in the state. Latent classes were identified for SES/comorbidities, barriers to care, and tumor characteristics that varied by race and age. Compared to white women, black women had lower SES (odds ratio (OR) 6.3, 95% confidence interval (CI) 5.2, 7.8), more barriers to care (OR 5.6, 95% CI 3.9, 8.1) and several aggregated tumor aggressiveness features. Compared to older women, younger women had higher SES (OR 0.5, 95% CI 0.4, 0.6), more barriers to care (OR 2.1, 95% CI 1.6, 2.9) and aggregated tumor aggressiveness features. CONCLUSIONS: CBCS3 is representative of North Carolina on comparable factors. Patterns of access to care and tumor characteristics are intertwined with race and age, suggesting that interventions to address disparities will need to target both access and biology.
Authors: Carol E DeSantis; Rebecca L Siegel; Ann Goding Sauer; Kimberly D Miller; Stacey A Fedewa; Kassandra I Alcaraz; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2016-02-22 Impact factor: 508.702
Authors: Carol E DeSantis; Stacey A Fedewa; Ann Goding Sauer; Joan L Kramer; Robert A Smith; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2015-10-29 Impact factor: 508.702
Authors: Stephanie B Wheeler; Jennifer C Spencer; Laura C Pinheiro; Lisa A Carey; Andrew F Olshan; Katherine E Reeder-Hayes Journal: J Clin Oncol Date: 2018-04-18 Impact factor: 44.544
Authors: Emma H Allott; Joseph Geradts; Stephanie M Cohen; Thaer Khoury; Gary R Zirpoli; Wiam Bshara; Warren Davis; Angela Omilian; Priya Nair; Rochelle P Ondracek; Ting-Yuan David Cheng; C Ryan Miller; Helena Hwang; Leigh B Thorne; Siobhan O'Connor; Traci N Bethea; Mary E Bell; Zhiyuan Hu; Yan Li; Erin L Kirk; Xuezheng Sun; Edward A Ruiz-Narvaez; Charles M Perou; Julie R Palmer; Andrew F Olshan; Christine B Ambrosone; Melissa A Troester Journal: Breast Cancer Res Date: 2018-02-06 Impact factor: 6.466
Authors: Marc A Emerson; Bryce B Reeve; Melissa B Gilkey; Shekinah N C Elmore; Sandi Hayes; Cathy J Bradley; Melissa A Troester Journal: J Cancer Surviv Date: 2022-09-14 Impact factor: 4.062
Authors: Gieira S Jones; Katherine A Hoadley; Halei Benefield; Linnea T Olsson; Alina M Hamilton; Arjun Bhattacharya; Erin L Kirk; Heather J Tipaldos; Jodie M Fleming; Kevin P Williams; Michael I Love; Hazel B Nichols; Andrew F Olshan; Melissa A Troester Journal: Breast Cancer Res Treat Date: 2022-01-16 Impact factor: 4.624
Authors: Sanah N Vohra; Katherine E Reeder-Hayes; Hazel B Nichols; Marc A Emerson; Michael I Love; Andrew F Olshan; Melissa A Troester Journal: Breast Cancer Res Treat Date: 2022-01-10 Impact factor: 4.624
Authors: Marc A Emerson; Yvonne M Golightly; Allison E Aiello; Katherine E Reeder-Hayes; Xianming Tan; Ugwuji Maduekwe; Marian Johnson-Thompson; Andrew F Olshan; Melissa A Troester Journal: Cancer Date: 2020-09-21 Impact factor: 6.860
Authors: Marc A Emerson; Katherine E Reeder-Hayes; Heather J Tipaldos; Mary E Bell; Marina R Sweeney; Lisa A Carey; H Shelton Earp; Andrew F Olshan; Melissa A Troester Journal: Curr Breast Cancer Rep Date: 2020-05-14
Authors: Austin D Williams; Meghan Buckley; Robin M Ciocca; Jennifer L Sabol; Sharon L Larson; Ned Z Carp Journal: Breast Cancer Res Treat Date: 2022-01-22 Impact factor: 4.872
Authors: Miguel A Simancas-Pallares; Jeannie Ginnis; William F Vann; Andrea G Ferreira Zandoná; Poojan Shrestha; John S Preisser; Kimon Divaris Journal: Community Dent Oral Epidemiol Date: 2021-05-13 Impact factor: 2.489
Authors: Gieira S Jones; Katherine A Hoadley; Linnea T Olsson; Alina M Hamilton; Arjun Bhattacharya; Erin L Kirk; Heather J Tipaldos; Jodie M Fleming; Michael I Love; Hazel B Nichols; Andrew F Olshan; Melissa A Troester Journal: Breast Cancer Res Date: 2021-08-03 Impact factor: 8.408